SEC Comment Letter 0000000000-23-008621 to Longboard Pharmaceuticals, Inc. (LBPH) (CIK 0001832168)
Longboard Pharmaceuticals, Inc. (LBPH) (CIK 0001832168)
Date: Aug. 8, 2023 · CIK: 0001832168 · Accession: 0000000000-23-008621
AI Filing Summary & Sentiment
File numbers found in text: 333-273712
Letter
United States securities and exchange commission logo August 8, 2023 Steven W. Spector, Esq. General Counsel Longboard Pharmaceuticals, Inc. 4275 Executive Square, Suite 950 La Jolla, California 92037 Re:Longboard Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed August 4, 2023 File No. 333-273712 Dear Steven W. Spector: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Steven M. Przesmicki, Esq.
Show Raw Text
United States securities and exchange commission logo
August 8, 2023
Steven W. Spector, Esq.
General Counsel
Longboard Pharmaceuticals, Inc.
4275 Executive Square, Suite 950
La Jolla, California 92037
Re:Longboard Pharmaceuticals, Inc.
Registration Statement on Form S-3
Filed August 4, 2023
File No. 333-273712
Dear Steven W. Spector:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Steven M. Przesmicki, Esq.